Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil in Bimaxillary Orthognathic Surgery
NCT02364765Completed
- Sponsor
- Universidade Federal de Minas Gerais
- Start
- Aug 2010
- Primary completion
- Jun 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of remifentanil, sponsored by Universidade Federal de Minas Gerais. Primary endpoints: Change in Hemoglobin, Change in Red Blood Cells and 2 more. Started Aug 2010; status: completed.
02
Drugs
remifentanil
Beyond the preview
Go deeper on NCT02364765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02364765.